Isoflurane USP 99.9 %

ISOFLURANE USP 99.9% is a high-purity inhalation anesthetic liquid used for general anesthesia. This product by Fresenius Kabi Canada Ltd. is designed for controlled administration in clinical settings.

ISOFLURANE USP 99.9% is primarily used for inducing and maintaining general anesthesia. It is administered via inhalation and is commonly employed in surgical procedures to ensure patient comfort and unconsciousness. This anesthetic is known for its rapid onset and adjustable depth of anesthesia, making it suitable for a variety of medical interventions.

When administered, ISOFLURANE USP 99.9% works by depressing the central nervous system, leading to a state of unconsciousness. Patients typically experience a loss of awareness and sensation, which is crucial for surgical procedures. The effects are carefully monitored to ensure patient safety and comfort throughout the procedure.

ISOFLURANE USP 99.9% should be handled with care, as it is a potent anesthetic. It should only be used by trained medical professionals in controlled environments. Proper ventilation and monitoring equipment are essential during its administration to manage any potential adverse reactions.

ISOFLURANE USP 99.9% may interact with other medications, particularly those that also affect the central nervous system. It is important to inform healthcare providers of all current medications to avoid potential interactions. Additionally, certain medical conditions may affect the safety and efficacy of this anesthetic, so a thorough patient history is crucial.